ScholarIQanswers from OpenAlex

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer

PaperCitations, authors & open-access status

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer have?

ScholarIQcitation count

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer has 166 citations in the OpenAlex counts ScholarIQ stores.

When was Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer published?

ScholarIQyear

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer has 2021 year in the ScholarIQ index.

What is the open-access status of Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer?

ScholarIQoa status

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer has gold oa status in the ScholarIQ index.

What is the DOI of Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer?

ScholarIQdoi

The DOI for Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer is on the source record.

What is the PMID of Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer?

ScholarIQpmid

The PMID for Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer is on the source record.

What is the OpenAlex record for Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer?

ScholarIQopenalex

The OpenAlex for Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial